Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata
- PMID: 29666002
- PMCID: PMC5909837
- DOI: 10.1016/j.cancergen.2018.01.001
Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata
Abstract
Black women are disproportionately affected by uterine leiomyomata (UL), or fibroids, compared to other racial groups, having a greater lifetime risk of developing UL and an earlier age of diagnosis. In order to elucidate molecular and genetic mechanisms responsible for the increased prevalence and morbidity associated with UL in black women, clinical, pathologic, cytogenetic, and select molecular profiling (MED12 mutation analysis) of 75 self-reported black women undergoing surgical treatment for UL was performed. Our observations are broadly representative of previous cytogenetic studies of UL: karyotypically abnormal tumors were detected in 30.7% of women and 17.4% of analyzed tumors. No notable association was observed between race and increased occurrence of cytogenetic abnormalities that might contribute to any population-specific morbidity or prevalence rate. Our data on MED12 mutation analyses (73.2% of tumors harbored a MED12 mutation) provide additional support for a significant role of MED12 in tumorigenesis. Although the effect of MED12-mediated tumorigenesis appears significant irrespective of race, other genetic events such as the distribution of karyotypic abnormalities appear differently in black women. This case series indicates that presently recognized genetic and molecular characteristics of UL do not appear to explain the increased prevalence and morbidity of UL in black women.
Keywords: Fibroids; clinical; cytogenetic; molecular; race.
Copyright © 2018 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors report no conflict of interest.
Similar articles
-
Multiomic analysis of uterine leiomyomas in self-described Black and White women: molecular insights into health disparities.Am J Obstet Gynecol. 2024 Sep;231(3):321.e1-321.e11. doi: 10.1016/j.ajog.2024.04.051. Epub 2024 May 7. Am J Obstet Gynecol. 2024. PMID: 38723985
-
MED12 mutation frequency in unselected sporadic uterine leiomyomas.Fertil Steril. 2014 Oct;102(4):1137-42. doi: 10.1016/j.fertnstert.2014.06.040. Epub 2014 Aug 6. Fertil Steril. 2014. PMID: 25108465
-
Cell cultures in uterine leiomyomas: rapid disappearance of cells carrying MED12 mutations.Genes Chromosomes Cancer. 2014 Apr;53(4):317-23. doi: 10.1002/gcc.22142. Epub 2014 Jan 21. Genes Chromosomes Cancer. 2014. PMID: 24446130
-
Genetic Mechanisms Driving Uterine Leiomyoma Pathobiology, Epidemiology, and Treatment.Genes (Basel). 2024 Apr 27;15(5):558. doi: 10.3390/genes15050558. Genes (Basel). 2024. PMID: 38790186 Free PMC article. Review.
-
Leiomyomata: heritability and cytogenetic studies.Hum Reprod Update. 2001 Jan-Feb;7(1):8-14. doi: 10.1093/humupd/7.1.8. Hum Reprod Update. 2001. PMID: 11212080 Review.
Cited by
-
Whole exon capture sequencing for identifying mutations associated with pulmonary benign metastasising leiomyoma.BMJ Case Rep. 2023 Mar 22;16(3):e251072. doi: 10.1136/bcr-2022-251072. BMJ Case Rep. 2023. PMID: 36948524
-
A Novel Cryptic t(2;3)(p21;q25) Translocation Fuses the WWTR1 and PRKCE Genes in Uterine Leiomyoma With 3q- as the Sole Visible Chromosome Abnormality.Cancer Genomics Proteomics. 2022 Sep-Oct;19(5):636-646. doi: 10.21873/cgp.20348. Cancer Genomics Proteomics. 2022. PMID: 35985686 Free PMC article.
-
Benign Metastasizing Leiomyomatosis to the Skin and Lungs, Intravenous Leiomyomatosis, and Leiomyomatosis Peritonealis Disseminata: A Series of Five Cases.Oncologist. 2022 Feb 3;27(1):e89-e98. doi: 10.1093/oncolo/oyab019. Oncologist. 2022. PMID: 35305104 Free PMC article.
-
Summary of the Proceedings of the Basic Science of Uterine Fibroids Meeting: New Developments February 28, 2020.F S Sci. 2021 Feb;2(1):88-100. doi: 10.1016/j.xfss.2020.11.001. Epub 2020 Nov 7. F S Sci. 2021. PMID: 34124698 Free PMC article.
-
Integrating Intersectionality Into the Exposome Paradigm: A Novel Approach to Racial Inequities in Uterine Fibroids.Am J Public Health. 2021 Jan;111(1):104-109. doi: 10.2105/AJPH.2020.305979. Epub 2020 Nov 19. Am J Public Health. 2021. PMID: 33211578 Free PMC article.
References
-
- Bulun SE. Uterine fibroids. N Engl J Med. 2013;369:1344–55. - PubMed
-
- Buttram VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36:433–45. - PubMed
-
- Stewart EA. Clinical practice. Uterine fibroids New Engl J Med. 2015;372:1646–55. - PubMed
-
- Lepine LA, Hillis SD, Marchbanks PA, Koonin LM, Morrow B, Kieke BA, et al. Hysterectomy surveillance--United States, 1980–1993. Mor Mortal Wkly Rep CDC Surveill Summ. 1997;46:1–15. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical